Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma.
Conclusions: VBT alone is as effective as EBRT+VBT in ensuring loco-regional control and achieving comparable survival rates, with fewer toxic effects for patients with stage I intermediate- and high-risk endometrial carcinoma. The dose escalation did not make a difference in the survival rates and was like in the other major trials (PORTEC-2).
PMID: 29789759 [PubMed]
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Cystitis | Dermatology | Endometrial Cancer | External Beam Therapy | Gastroenterology | India Health | Skin | Statistics | Study | Toxicology